Van Egeren et al, Harvard, PLOS, explains how mutations render the mandated products useless but still has enough RBD integrity to cause infection. The worldwide failure of the program occurred with a narrow band of epitopes had no hope for durable protection. Anticipated.
View PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081162/pdf/pone.0250780.pdf
This is where Klaus has his comments.
View PDF Directly: https://www.doctorstalk.ch/wp-content/uploads/2022/06/959-Article-Text-7803-1-10-20210301.pdf
Source: https://riviste.fupress.net/index.php/subs/article/view/959
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities (by the WHO)
WHO never supported asymptomatic testing for air travel since it was not supported by scientific studies. Most important issue is to stay off the planes if acutely sick and airlines should be flexible with changes. Testing travelers never had a role from the very beginning.
Direct PDF: https://www.doctorstalk.ch/wp-content/uploads/2022/06/WHO-2019-nCoV-lab-testing-2021.1-eng.pdf
Source: https://www.who.int/publications/i/item/WHO-2019-nCoV-lab-testing-2021.1-eng
Letter to FDA from Congress and Senate on rationale since so many children have already had the infection and its too late from them to take one of the products. Why take the risk without any assurances of long term safety? 19 questions, 18 signatures. Lets here some answers!
Corbin et al CIVETs, genetic products essentially useless in HIV. Best to RX viral illness early and avoid complications. Should not rely upon serial administration of ineffective biologicals. Keep HIV as uncomplicated as possible–skilled doctors can manage it it occurs.
